Combined oral contraceptives have been shaped throughout their history by one serious harm — venous thromboembolism — and by successive attempts to reduce it, mostly by lowering the ethinylestradiol dose. A clinical review in Obstetrics and Gynecology argues that the formulations containing a natural estrogen rather than ethinylestradiol now have a better safety profile while keeping high contraceptive efficacy, and should likely be first line for a patient starting a combined pill.
That is a change of default rather than a safety signal about existing users. A woman who has taken the same ethinylestradiol pill for years without a problem has already demonstrated the thing the change is meant to avoid; the argument applies to the next prescription you write for someone who has never taken one.
It has a practical limit. Natural-estrogen formulations are not stocked everywhere and are not priced like the older pills, and an effective contraceptive a woman can afford and obtain beats a theoretically safer one she cannot. Where the choice exists, make it deliberately and know which hormone is in the packet you are handing over — the review's real point is that clinicians prescribe combined pills as a class and the formulations are not interchangeable.
- For a new start, ask specifically whether a natural-estrogen formulation is available to this patient.
- Do not switch a settled long-term user on this evidence alone.
- Take the venous thromboembolism history properly — personal and first-degree family — whichever formulation you choose.
- Know the progestin as well as the estrogen; the non-contraceptive benefits differ between them.
- Where cost or supply decides it, say so to the patient rather than leaving her to discover the difference at the pharmacy.
Why it matters
The default new-start prescription in most clinics is still ethinylestradiol, and this argues the default should move.
Don't overread it
This is a clinical review's recommendation, not a head-to-head randomised trial showing fewer clots with natural-estrogen pills.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for obstetrics & gynaecology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free